Tolerogenic dendritic cell therapy in type 1 diabetes; a phase 1b safety and immunological effecitivity study

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508558-25-01

Enrollment

Registered

2024-10-30

Start date

2024-12-02

Completion date

Unknown

Last updated

2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026